Key facts
- Akina’s last known valuation is $11.1M (Jan 2025).
- It has raised $4.9M; the latest was Accelerator/Incubator in May 2025.
- Notable investors include Venture Kick, Innosuisse, Kickfund, Freigeist, AI Startup Center — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Akina
- ·The full record, as it builds
Funding rounds
No funding rounds for Akina are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Akina
Developer of artificial intelligence healthcare software designed to embrace movement's full potential through AI-enhanced physiotherapy. The company offers services that empower patients during independent physiotherapy at home and connect them to healthcare providers for remote therapeutic monitoring, personalized guidance through proprietary AI motion analysis and media streaming algorithms, and automated case review and feedback generation for therapists, enabling patients to ensure the efficiency of care delivery and improving clinical outcomes.
- Sector
- Healthcare
- HQ
- Zürich, Switzerland
- Founded
- 2021
- Employees
- 20
- Website
- akina.health/
- Ownership
- Privately Held (backing)
Akina doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Akina shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Akina in its N-PORT filings yet. We sweep new filings monthly.